Crossmark

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Crossref DOI link: https://doi.org/10.1038/s41388-018-0617-1

Published Online: 2018-12-10

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kessler, Brittelle E.

Mishall, Katie M.

Kellett, Meghan D.

Clark, Erin G.

Pugazhenthi, Umarani

Pozdeyev, Nikita

Kim, Jihye https://orcid.org/0000-0002-0338-2329
Tan, Aik Choon https://orcid.org/0000-0003-2955-8369
Schweppe, Rebecca E. https://orcid.org/0000-0001-7502-0151
License Information

Text and Data Mining valid from 2018-12-10
More Information

Article History

Received: 20 May 2018

Revised: 20 November 2018

Accepted: 23 November 2018

First Online: 10 December 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below